Buy Day today: Good (67) Broad market participation · no major macro event

Amphastar Pharmaceuticals, Inc. (AMPH)

Healthcare Drug Manufacturers - Specialty & Generic

20.20 $

+1.4% vs. previous close

Closing price · As of: 3. Aug 2026

Amphastar Pharmaceuticals, Inc. (AMPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,629 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet AMPH
Tick rows to compare them in a chart (up to 4)	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	389	390	428	455	514	587	631	672	742	1,513	1,577	1,629
Current Assets	198	176	184	188	220	255	280	318	378	490	534	636
Cash	68	66	72	66	86	76	93	126	156	144	152	170
Cash & Short-Term Investments	68	66	73	68	89	90	106	137	176	257	222	283
Receivables	23	33	27	36	52	45	66	79	89	115	138	144
Inventory	82	71	80	64	69	111	97	93	104	106	154	177
Property, Plant & Equipment	138	142	153	185	210	234	260	244	238	–	–	–
Goodwill	4.5	3.7	4.0	4.5	4.0	3.6	3.9	3.3	3.1	3.2	3.0	3.4
Intangible Assets	38	36	46	41	38	38	37	36	34	610	588	563
Total Liabilities	108	95	98	117	149	159	183	226	213	873	845	840
Current Liabilities	63	60	61	67	107	90	112	104	95	225	174	158
Short-Term Debt	7.6	11	5.4	6.3	18	11	16	5.2	6.0	4.3	7.0	9.6
Accounts Payable	10	14	20	17	31	25	24	22	21	25	31	33
Long-Term Debt	36	30	32	41	32	39	34	75	73	590	602	609
Shareholders' Equity	282	296	329	337	332	381	402	446	529	639	732	789
Retained Earnings	63	60	71	76	67	116	118	180	272	409	569	667
Shares Outstanding	42	45	48	48	46	50	49	50	52	53	52	48

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings